Sagimet Bio­sciences files again for an IPO af­ter re­leas­ing NASH da­ta

Two years af­ter fil­ing to go pub­lic and then back­ing out, Sagimet Bio­sciences has made plans to try again on an IPO.

The Cal­i­for­nia biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.